Smartleaf Asset Management’s AstraZeneca AZN Stock Holding History

Smartleaf Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.99M	Hold	10,439	–	–	0.06%	256
2026 Q1	$2.02M	Sell	10,439 -3,858	-27%	-$744K	0.07%	242
2025 Q4	$2.65M	Buy	14,297 +1,923	+16%	+$337K	0.1%	178
2025 Q3	$1.83M	Buy	12,374 +4,683	+61%	+$709K	0.11%	200
2025 Q2	$1.07M	Sell	7,691 -464	-6%	-$65K	0.09%	240
2025 Q1	$1.2M	Buy	8,155 +993	+14%	+$144K	0.12%	195
2024 Q4	$939K	Buy	7,162 +2,624	+58%	+$367K	0.1%	226
2024 Q3	$704K	Buy	4,538 +1,126	+33%	+$182K	0.09%	248
2024 Q2	$533K	Buy	3,412 +928	+37%	+$140K	0.09%	238
2024 Q1	$339K	Buy	2,484 +437	+21%	+$57.9K	0.07%	263
2023 Q4	$275K	Buy	+2,047	New	+$266K	0.07%	260

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Smartleaf Asset Management's AZN Position: Q2 2026 in Review

Smartleaf Asset Management held its AstraZeneca (AZN) position steady in Q2 2026 at 10,439 shares worth $1.99M. The position accounts for 0.06% of the portfolio, ranked #256.

Smartleaf Asset Management first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.65M in Q4 2025. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Smartleaf Asset Management held 10,439 shares of AstraZeneca worth $1.99M as of Q2 2026.
Smartleaf Asset Management left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.06% of Smartleaf Asset Management's portfolio in Q2 2026, its #256 holding.
Smartleaf Asset Management first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
Smartleaf Asset Management's AstraZeneca position peaked at $2.65M in Q4 2025.
1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.